Literature DB >> 28934188

Effect of aldosterone antagonists on obstructive sleep apnea in patients with resistant hypertension: a systematic review and meta-analysis.

W-D Zhang1,2, J-W Zhang1, K-F Wu1, X Chen2, Y-P Wang1, L-H Zhou1, H-T Wang1, S-M Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28934188     DOI： 10.1038/jhh.2017.70

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  6 in total

1.  Effect of eplerenone on the severity of obstructive sleep apnea and arterial stiffness in patients with resistant arterial hypertension.

Authors:  Beata Krasińska; Angelika Miazga; Szczepan Cofta; Ludwina Szczepaniak-Chicheł; Tomasz Trafas; Zbigniew Krasiński; Katarzyna Pawlaczyk-Gabriel; Andrzej Tykarski
Journal:  Pol Arch Med Wewn       Date:  2016-05-27

2.  Treatment of primary aldosteronism is associated with a reduction in the severity of obstructive sleep apnoea.

Authors:  M J Wolley; E Pimenta; D Calhoun; R D Gordon; D Cowley; M Stowasser
Journal:  J Hum Hypertens       Date:  2017-04-06       Impact factor: 3.012

3.  Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea.

Authors:  Lirui Yang; Huimin Zhang; Menggengtuya Cai; Yubao Zou; Xiongjing Jiang; Lei Song; Erpeng Liang; Jin Bian; Haiying Wu; Rutai Hui
Journal:  Clin Exp Hypertens       Date:  2016-07-01       Impact factor: 1.749

4.  Management of obstructive sleep apnea in adults: A clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Jon-Erik C Holty; Douglas K Owens; Paul Dallas; Melissa Starkey; Paul Shekelle
Journal:  Ann Intern Med       Date:  2013-10-01       Impact factor: 25.391

Review 5.  Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis.

Authors:  G Liu; X X Zheng; Y L Xu; J Lu; R T Hui; X H Huang
Journal:  J Hum Hypertens       Date:  2014-07-31       Impact factor: 3.012

6.  Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report.

Authors:  K Gaddam; E Pimenta; S J Thomas; S S Cofield; S Oparil; S M Harding; D A Calhoun
Journal:  J Hum Hypertens       Date:  2009-12-17       Impact factor: 3.012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.